More than 350 community pharmacists gathered in the Washington, D.C. area for the NCPA 2016 Congressional Pharmacy Summit May 24-25 to advocate for pharmacy choice for patients and greater drug pricing transparency. During the Summit, attendees heard from Rep. Cathy McMorris Rodgers (R-Wash.), a founding member of the Congressional Pharmacy Caucus and longtime supporter of NCPA's legislative priorities. McMorris Rodgers was named a "Friend of Pharmacy" for her continued willingness to fight for constructive, pro-community pharmacy legislation over the years.
Attendees also participated in panel discussions on the legislative outlook, lobbying 101, and DIR fees. After the workshops, attendees conducted 600+ visits to more than 250 U.S. House and Senate offices to advocate for:
Creating greater transparency for generic prescription drug reimbursements in government-run programs by enacting H.R. 244, the MAC Transparency Act;
Requiring Medicare Part D and pharmacy benefit manager (PBM) corporations to report pharmacy price concessions when prescription drugs are dispensed, which are called "direct and indirect remuneration" (DIR fees);
Pushing to include an any willing pharmacy provision in federal programs by enacting H.R. 793 / S. 1190, the Ensuring Seniors Access to Local Pharmacies Act, which would allow community pharmacies in medically underserved areas to serve Medicare Part D beneficiaries as long as the pharmacy accepts the drug plan's terms and conditions; and
- Increasing Medicare beneficiary access to health care services delivered by pharmacists by recognizing them as health care providers under Medicare Part B by enacting H.R. 592 / S. 314, the Pharmacy and Medically Underserved Areas Enhancement Act.